Molecular and Cellular Biology, July 1999, p. 4653-4663, Vol. 19, No. 7
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Induction of Apoptosis by
Double-Stranded-RNA-Dependent Protein Kinase (PKR) Involves the
Subunit of Eukaryotic Translation Initiation Factor 2 and
NF-
B
Jesús
Gil,1
José
Alcamí,2 and
Mariano
Esteban1,*
Department of Molecular and Cellular Biology,
Centro Nacional de Biotecnología, Consejo Superior de
Investigaciones Científicas, Campus Universidad Autónoma,
28049 Madrid,1 and Centro de
Investigación, Hospital 12 de Octubre, Carretera de
Andalucía 5.400, 28041 Madrid,2 Spain
Received 28 December 1998/Returned for modification 5 February
1999/Accepted 25 March 1999
 |
ABSTRACT |
The double-stranded (ds) RNA-dependent protein kinase (PKR) is a
key mediator of antiviral effects of interferon (IFN) and an active
player in apoptosis induced by different stimuli. The translation
initiation factor eIF-2
(
subunit of eukaryotic translation
initiation factor 2) and I
B
, the inhibitor of the transcription
factor NF-
B, have been proposed as downstream mediators of PKR
effects. To evaluate the involvement of NF-
B and eIF-2
in the
induction of apoptosis by PKR, we have used vaccinia virus (VV)
recombinants that inducibly express PKR concomitantly with a dominant
negative mutant of eIF-2
or a repressor form of I
B
. We found
that while expression of PKR by a VV vector resulted in extensive
inhibition of protein synthesis and induction of apoptosis,
coexpression of PKR with a dominant negative mutant of eIF-2
(Ser-51
Ala) reversed both the PKR-mediated translational block and
PKR-induced apoptosis. Coexpression of PKR with a repressor form of
I
B
(Ser-32,36-Ala) also leads to the inhibition of apoptosis by
abolishing NF-
B induction, while translation remains blocked. Treating cells with two different proteasome inhibitors which block
I
B
degradation, prevented PKR-induced apoptosis, supporting results from coexpression studies. Biochemical analysis and transient assays revealed that PKR expression by a VV vector induced NF-
B binding and transactivation. In addition, upregulation of Fas mRNA
transcription occurred during PKR activation. Our findings provide
direct evidence for the involvement of eIF-2
and NF-
B in the
induction of apoptosis by PKR.
 |
INTRODUCTION |
Apoptosis is a genetic program of
cell death initiated by many different stimuli (reviewed in reference
64). One trigger is the accumulation of
double-stranded RNA (dsRNA) in the cytoplasm of eukaryotic cells
(28), an event that is principally thought to result from
the infection of cells by viruses (25). The accumulation of
dsRNA activates at least two interferon (IFN)-induced pathways (reviewed in reference 53), and each one
independently drives cells to a translational block and to apoptosis
(17, 33). One of these pathways, the 2-5A system, is
composed of the dsRNA-activated 2-5A synthetases and a latent
endoribonuclease, RNase L, that upon activation by 2-5A oligoadenylates
cleaves single-stranded RNA, causing the abrogation of translation.
This pathway also activates apoptosis in different systems (13,
17, 67). Another IFN-induced pathway involves the
serine-threonine protein kinase activated by dsRNA (called PKR
[41]; for the revision, see reference 44). PKR has two known cellular substrates: eIF-2
(
subunit of eukaryotic translation initiation factor 2 [48]), which upon phosphorylation abrogates
translation initiation, and I
B
(29), the inhibitor of
the transcription factor NF-
B (for a review, see reference
6). PKR conditions cellular apoptosis in response to
activation by various stimuli (15) or when it is
overexpressed (33). Although PKR has been implicated in the
antiviral and anticellular actions of IFN, little is known relative to
the mechanism of PKR-mediated induction of apoptosis (15, 35,
51).
In most cells, NF-
B heterodimers are present in the cytoplasm
forming an inactive complex by interacting with the I
B family of
proteins. In response to a variety of activators, the prototypic member
of this family of inhibitors, I
B
, is phosphorylated at serines 32 and 36, rendering the factor susceptible to proteolysis via the
ubiquitin-proteasome pathway (47). This event unmasks a
nuclear localization sequence of the transactivating heterodimers, allowing NF-
B translocation to the nucleus. There, the complex binds
to
B consensus motifs in the DNA, upregulating the transcription of
many genes. NF-
B has been added recently to the list of
apoptosis-associated transcription factors. Overexpression of one of
the NF-
B subunits, c-rel, in chick bone marrow cells leads to
apoptosis (1). Additionally, inhibition of NF-
B activity
by different approaches abrogates virus-induced cell death in AT-3
cells (37), prevents induction of apoptosis by DNA-damaging
agents (26), and blocks apoptosis caused by serum
deprivation in HEK cells (21). Hence, it seems plausible
that at least in some cell lines, NF-
B activation, alone or together
with other events, is necessary to induce apoptosis. However, NF-
B
activity also has preventive apoptotic roles in response to certain
stimuli, such as when cells are exposed to tumor necrosis factor
(TNF-
), radiation, or daunorubicin (7, 60, 62) or upon
oncogenic Ras expression (39). As yet, there is no evidence
of a role for NF-
B in the induction of apoptosis by PKR.
Many of the biological effects mediated by PKR, such as the control of
virus pathogenesis, are related to its ability to inhibit protein
synthesis (27, 49). PKR-induced translational control is a
result of phosphorylation of serine 51 in eIF-2
(18). Phosphorylation of eIF-2
inhibits initiation events due to the lack
of available eIF-2-GTP-Met-tRNAmet ternary complexes (for
a review, see reference 22). Recently, eIF-2
phosphorylation by PKR and concomitant inhibition of translation have
been shown to play a role in apoptosis induction upon TNF-
treatment
of 3T3 cells (51).
In view of the biological importance of PKR, we have addressed the
significance of PKR substrates, I
B
and eIF-2
, in PKR-induced apoptosis. We have taken advantage of vaccinia virus (VV) recombinants that express PKR under the regulation of the Escherichia coli lacI operator-repressor system. Upon treatment of the infected cells with the inducer IPTG
(isopropyl-
-D-thiogalactopyranoside), PKR is activated,
translation is downregulated, and the cells die by apoptosis
(33). To define the role of eIF-2
and NF-
B on
apoptosis mediated by PKR, we have coexpressed PKR together with a
dominant negative form of the translation factor eIF-2
or a
repressor mutant of the transcriptional regulatory factor I
B
. Our
findings support the involvement of these translation and transcription
controlling factors in PKR-mediated apoptosis.
(This work was presented at the Second Joint Meeting of the
International Cytokine Society and the International Society for Interferon and Cytokine Research, Jerusalem, Israel, 25 to 30 October
1998.)
 |
MATERIALS AND METHODS |
Materials.
The proteasome inhibitors
Cbz-Ile-Glu(O-t-Bu)-Ala-Leucinal (PSI; Sigma) and lactacystin
(Calbiochem) were prepared in dimethyl sulfoxide (DMSO) as 6 and 4 mM
stock solutions, respectively, and stored at
20°C. In experiments
that compared cells treated with different concentrations of PSI or
lactacystin, the amount of DMSO per well was maintained constant.
Polyinosinic polycytidylic acid (pIC; Boehringer Mannheim) was prepared
according to the manufacturer's instructions as a 10-mg/ml stock
solution and stored at
20°C. Human TNF-
(Sigma) was prepared as
a 5-µg/ml stock solution and stored in aliquots at
80°C. All
other reagents, except where indicated, were from Merck, Boehringer
Mannheim, or Sigma.
Plasmids.
Plasmid pPR15 expresses the luciferase gene under
the control of a constitutive VV p4b promoter and has been previously
described (46). The pI
B
M, pI
B
Wt, and peIF-2
NP plasmids were derived from the VV insertional vector pPR35 designed
for IPTG-inducible expression of genes (46). pI
B
M and
Wt were generated by cloning a
HindIII/Klenow/BamHI fragment excised from
pcDNA3-I
B
M and pcDNA3-I
B
Wt, respectively (47),
into SmaI/BamHI-digested pPR35. Plasmid peIF-2
NP was constructed by cloning an EcoRV/Asp718 pSP72-2
Ser-51
Ala fragment (42) into
SmaI/Asp718-digested pPR35.
The long terminal repeat (LTR)-luciferase vector (2)
contains the U3+R regions (
640/+78 fragment) of the human
immunodeficiency virus (HIV)-LTR cloned into the pC-luc plasmid. The
3enh-
B-ConA-luc plasmid (3) carries a luciferase gene
under the control of three synthetic copies of the
B consensus of
the immunoglobulin
-chain promoter cloned into the BamHI
site located upstream of the conalbumin transcription start site.
Cells and viruses.
African green monkey kidney cells BSC-40
(ATCC CCL-26) were grown in Dulbecco modified Eagle medium (DMEM)
supplemented with 10% heat-inactivated newborn calf serum (NCS). Mouse
3T3 cells (ATCC CCL-92) were grown in DMEM supplemented with 10% fetal
calf serum (FCS). Human bone osteosarcoma TK
143B cells
(ECACC 91112502) were maintained in DMEM supplemented with 10% FCS and
15 µg of 5-bromo-2-deoxyuridine (BUdR) per ml. HeLa cells (ECACC
85060701) were grown in DMEM supplemented with 10% NCS. 3T3-like cells
derived from homozygous PKR knockout mice (PKR0/0) or
wild-type animals with the same genetic background (PKR+/+)
(both a generous gift of C. Weissmann, University of Zurich, Zurich,
Switzerland) were grown in DMEM supplemented with 10% FCS. After mock
inoculation or viral adsorption, cells were maintained with DMEM
supplemented with 2% NCS or 2% FCS (supplemented with BUdR for 143B cells).
The recombinant VV expressing IPTG-inducible PKR (called WR 68K before,
and VV PKR herein) was described previously (33). Virus
vTF7-3 (herein VT7) contains the bacteriophage T7 RNA polymerase gene
under the control of a virus constitutive promoter as described earlier
(20). VVRL was obtained by insertion of pTM-RL into the
thymidine kinase locus of wild-type VV Western reserve (WR) strain by
homologous recombination (16). VV hbcl2 inducibly expresses
the human oncoprotein bcl2 as previously described (35). VV
abcl2 constitutively expresses the African swine fever virus (ASFV)
A179L gene, a viral homologue of bcl2, as shown before (11).
VV I
B
M, VV I
B
Wt, and VV eIF-2
NP were generated by
homologous recombination of their respective pPR35 derived-plasmid with
WR strain of VV in TK
143B cells, as previously described
(34).
Analysis of cell viability.
BSC-40 cells were seeded in
96-well plates in a total volume of 100 µl and incubated for 24 h at 37°C in 5% CO2, followed by the addition to each
well of 10 µl of a stock solution of methyl thiazol tetrazolium (MTT)
prepared in phosphate-buffered saline (PBS) at a concentration of 5 mg/ml. Plates were further incubated for 3 h. The formazan salts
were solubilized by adding 150 µl of 10% Triton X-100 in acidified
isopropanol. Plates were rocked for 10 min and the absorbances at 540 and 690 nm were measured in a spectrophotometer.
Measurement of the extent of apoptosis.
The cell death
detection enzyme-linked immunosorbent assay (ELISA) kit (Boehringer
Mannheim) was used according to the manufacturer's instructions. This
assay is based on the quantitative sandwich enzyme immunoassay
principle and uses mouse monoclonal antibodies directed against DNA and
histones to estimate the amount of cytoplasmic histone-associated DNA.
Transient luciferase reporter assays.
In order to check the
translational state of cells, semiconfluent BSC-40 cells grown in
12-well plates were infected with the viruses indicated and transfected
after 1 h of virus adsorption with 0.5 µg of pPR15 per well by
using Lipofectamine reagent (GIBCO-BRL) according to manufacturer's
directions for an additional 5 h. Where indicated, 5 mM IPTG was
added to the cultures at the time of transfection. Cells were harvested
24 h after infection and lysed, and luciferase activity was
determined as previously described (10). The NF-
B
reporter assay was similar, but the assay was performed with HeLa cells
grown in 6-well plates, and the cells were transfected with
LTR-luciferase or with 3enh-
B-ConA-luc plasmid (2 µg of DNA per well).
Metabolic labeling of proteins.
BSC-40 cells cultured in
12-well plates were infected with the viruses indicated and rinsed
three times with Met-Cys-free DMEM 30 min prior to labeling. After
incubation for an additional 30 min at 37°C with Met-Cys-free DMEM,
the medium was removed, and 50 µCi of [35S]Met-Cys
Promix (Amersham) per ml in Met-Cys-free DMEM was added for an
additional hour. After three washes with PBS, cells were harvested in
lysis buffer (150 mM KCl, 10% glycerol, 1 mM dithiothreitol (DTT), 5 mM magnesium acetate, 0.5% Nonidet P-40). The protein concentration
was determined by using the bicinchoninic acid assay (BCA; Pierce) with
bovine serum albumin (BSA) as a standard. An aliquot of the cell lysate
was diluted in a 0.1-mg/ml BSA solution; the proteins were then
precipitated with 5% trichloroacetic acid and collected on glass fiber
filters by using a vacuum manifold instrument (Millipore). Filters were
dried, and the radioactivity was counted in a scintillation counter by
using liquid scintillation cocktail.
Immunoblotting.
Rabbit polyclonal antibody specific for
RNase L was as previously described (16). Mouse monoclonal
antibody specific for eIF-2
was a gift from César de Haro
(Centro de Biologia Molecular Severo Ochoa, Madrid, Spain) and M. J. Clemens (St. George's Hospital, London, United Kingdom). Mouse
monoclonal antibody for SV5 tag was obtained from R. E. Randall
(University of Glasgow, Glasgow, Scotland) through the NIBSC-MRC AIDS
Reagent Project. A peptide spanning amino acids 539 to 551 of the human
PKR was synthesized to produce antibodies against PKR. Polyclonal
rabbit antibody specific for PKR was obtained after repeated
immunizations with the purified peptide coupled to keyhole limpet
hemocyanin. Rabbit antiserum directed against phosphoserine 32-I
B
that specifically recognizes the phosphorylated form of the protein
(9) was purchased from New England Biolabs. Monoclonal
antibody (AC-74) for mouse beta-actin was from Sigma. Secondary
antibodies were purchased from Cappel.
For immunoblot analysis, total cell extracts were boiled in Laemmli
sample buffer, and proteins were fractionated by 10 or 12% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). After
electrophoresis, proteins were transferred to nitrocellulose paper by
using a semidry blotting apparatus (Gelman Sciences). Filters were
mixed with antiserum in PBS containing nonfat dry milk at 5% (BLOTTO),
incubated overnight at 4°C, washed three times with PBS, and further
incubated with secondary antibody coupled to horseradish peroxidase in
BLOTTO. After being washed with PBS, the immunocomplexes were detected
by using enhanced chemiluminescence Western blotting reagents
(Amersham). Exposure of filters to Kodak X-Omat films was performed for
times varying from 3 to 5 min, as needed.
Gel retardation assay.
Nuclear extracts from HeLa cells were
prepared as previously described (4). First, 3 µg of
nuclear extract was analyzed as described previously by using
[
-32P]dCTP-labeled double-stranded synthetic wild-type
HIV enhancer oligonucleotide
5'-AGCTTACAAGGGACTTTCCGCTGGGGACTTTCCAGGGA-3' containing the
two
B consensus motifs. The composition of the binding buffer included 25 mM HEPES, 1 mM EDTA, 3.5 mM spermidine, 6 mM
MgCl2, 100 mM NaCl, 0.15% Nonidet P-40, 10% glycerol, 5 mM DTT, 0.5 mg of BSA per ml, and 25 µg of poly(dI-dC) per ml.
 |
RESULTS |
Coexpression of PKR and a nonphosphorylated mutant form of eIF-2
inhibits apoptosis induction by PKR.
We previously described an
inducible system based on VV recombinants capable of expressing the
IFN-induced enzymes, PKR, 2-5A synthetase, and RNase L, and we have
shown that expression of these enzymes in an activated form triggers
apoptosis (17, 33). Result from this inducible virus-cell
system have been confirmed by others with transfected cells and with
cells derived from PKR and RNase L gene knockout mice (13, 15,
67). The VV inducible system was also used to identify apoptotic
viral genes (54) and cellular and viral inhibitors of
apoptosis (11, 35). Nonphosphorylatable PKR substrates were
expressed in the VV-inducible system in order to evaluate their role in
PKR-induced apoptosis. Expression of a 51A nonphosphorylatable form of
eIF-2
has been shown to abrogate the effects of eIF-2
phosphorylation on protein synthesis (18). The construction
of the VV vector and eIF-2
protein levels produced during infection,
in the absence or presence of IPTG, are presented in Fig.
1. Immunoblot analysis with specific
monoclonal antibody revealed that the recombinant protein was induced
by 6 h postinfection (hpi) and accumulated during infection. When
BSC-40 cells are infected with a VV recombinant expressing PKR, severe
apoptosis is induced as defined by several criteria: DNA ladder
formation, cell shrinkage, formation of apoptotic bodies, and
condensation of chromatin (33). The extent of apoptosis was
quantified by using a standard ELISA assay (17) which, as
indicated in Fig. 2A (column 1), shows
that expression of PKR induces severe apoptosis. As expected in this
virus-cell system, wild-type VV does not induce apoptosis (column 6).
To evaluate the interaction of eIF-2
and PKR in apoptosis, we
coinfected BSC-40 cells with VV PKR and VV eIF-2
NP that expresses
eIF-2
51A. The apoptosis-induced by PKR was abrogated by
coexpression of eIF-2
NP (Fig. 2A, column 2) in an eIF-2
NP
concentration-dependent manner (column 3). Inhibition of apoptosis by
eIF-2
NP expression correlated with its ability to reverse a
translational block induced by PKR (Fig. 2B). Based on Western blotting
with specific antibodies, the PKR levels in lanes 1, 2, and 3 were
similar (Fig. 2C). The production of eIF-2
NP is also shown in Fig.
2C. In order to gain insight into the temporal pattern of the
translational block induced by PKR, we carried out metabolic
pulse-labeling experiments at different times postinfection. In support
of previous data (34), upon PKR expression, at 12 hpi
translation decreased 80% compared to control values. In contrast,
coexpression of PKR and eIF-2
NP partially rescued the inhibition of
protein synthesis (data not shown). Significantly, the expression of
eIF-2
NP prolonged the ability of cells to engage in protein
synthesis compared to VV PKR-infected cells. In conclusion, the
expression of a mutant nonphosphorylatable form of eIF-2
overrides
the PKR-induced translational block and also inhibits PKR-mediated
apoptosis.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
Inducible expression of a dominant negative eIF-2
mutant form by a VV recombinant. (A) Map of the pPR35 derived peIF-2
NP (S51A). The plasmid contains an IPTG-inducible copy of eIF-2 NP
(S51A) under the regulation of a hybrid promoter consisting of the VV
p4b promoter fused to two lacI operator (op) units. The
plasmid also contains the lacI repressor gene under the
control of the VV p7.5 promoter and was used to obtain recombinant VV
by homologous recombination in TK 143B cells. (B) Time
course analysis of IPTG-dependent expression of eIF-2 NP by the VV
eIF-2 NP. BSC-40 cells were infected with 4 PFU of the virus per
cell and were treated with or without 1.5 mM IPTG, scraped, and
collected at the indicated times postinfection. Extracts were lysed,
and equal amounts of protein as determined by BCA were analyzed by
SDS-PAGE in conjunction with Western blotting with an eIF-2
monoclonal antibody.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
VV eIF-2 NP rescues translation inhibition and
prevents PKR-induced apoptosis. (A) BSC-40 cells grown in 12-well
plates were infected at a total of 9 PFU/cell with the viruses
indicated in the presence of 5 mM IPTG unless stated otherwise,
transfected 1 h later with 0.5 µg of pPR15, and harvested at 24 hpi for the determination of apoptosis. Mean values of triplicates of
the determined absorbance at 405 nm with standard deviations are given.
Columns: 1, 3 PFU of VV PKR and 6 PFU of VV per cell; 2, 3 PFU of VV
PKR, 3 PFU of VV eIF-2 NP, and 3 PFU of VV per cell; 3, 3 PFU of VV
PKR and 6 PFU of VV eIF-2 NP per cell; 4, 6 PFU of VV eIF-2 NP
and 3 PFU of VV per cell, without adding IPTG; 5, 6 PFU of VV eIF-2
NP and 3 PFU of VV per cell, but with IPTG; 6, 9 PFU of VV per cell.
(B) Samples from the same experiment were harvested and lysed in buffer
for luciferase determination as described in Materials and Methods.
Mean values of triplicates with the standard deviations are given of
the relative luciferase units measured in equal extracts. (C)
Immunoblot analysis of PKR and eIF-2 NP of the same samples used in
panels A and B.
|
|
PKR mediates phosphorylation of I
B
on Ser-32 induced by pIC
treatment.
In addition to its role as a regulator of translation,
PKR has been implicated in the control of transcription (29, 30, 44). PKR has been proposed to phosphorylate I
B
, the
inhibitor of NF-
B-dependent transcription (29). Although
PKR has been clearly shown to mediate NF-
B activation, some doubt
exists regarding its role in directly phosphorylating I
B
(32). Phosphorylation of I
B
on serine residues 32 and
36 is the first step of the most common and accepted mechanism of
NF-
B activation (52), but another atypical mechanism
involving tyrosine phosphorylation has been proposed (24).
To gain insight into the in vivo mechanism of PKR-induced NF-
B
activation, it was necessary to establish that I
B
phosphorylation
occurs specifically on serine 32. 3T3-like PKR knockout cells
(PKR0/0) or PKR+/+ cells were treated with pIC,
and the degree of I
B
phosphorylation on serine 32 was tested by
using a phosphorylation state-specific antibody (9). As
determined by Western blotting (Fig. 3,
upper panel), treatment with pIC for 30 min induces this
phosphorylation specifically in cells containing PKR but not in
PKR0/0 cells (compare lanes 3 and 6). As a control, both
cell lines were treated with TNF-
, a powerful activator of NF-
B
that has been shown to induce this transcription factor independently
of PKR (30). We observed that I
B
phosphorylation on
serine 32 upon TNF-
treatment occurred both in PKR0/0
and PKR+/+ cells to a similar degree, thus supporting
previous evidence of NF-
B induction in response to TNF-
independent of PKR (30). As a control to check equivalent
protein loading on the gel, the membrane was blotted with a monoclonal
antibody directed against mouse beta-actin (Fig. 3, lower panel).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
PKR mediates pIC-induced phosphorylation of I B on
serine 32. PKR0/0 and PKR+/+ cells grown in
6-well plates were serum starved for 3 h and then transfected with
7 µg of pIC per well with Lipofectamine or just transfected with
Lipofectamine as a mock negative control (M). Cells were collected 30 min posttreatment. For the PSI-TNF- treatment (referred to as
TNF- ), cells were serum starved for 2 h, and then 60 µM PSI
was added for one additional hour before treatment with 50 ng of
TNF- per ml during 3 h in the presence of 60 µM PSI in order
to achieve the accumulation of the serine 32-phosphorylated form of
I- B . At the indicated times, the cells were washed with PBS and
lysed in the plates by adding 200 µl of 1× Laemmli buffer,
collected, cooled on ice, and sonicated twice for 10 s. Clarified
extracts were separated by SDS-12% PAGE, transferred to
nitrocellulose membrane, and immunoblotted with antibodies against
phosphoserine 32 I B (upper panel) and -actin (lower panel).
|
|
PKR expression from a VV vector induces NF-
B binding and
transactivation.
Many viruses are known to interfere with the
mechanism of NF-
B activation, inhibiting it (43) or
inducing it (5). Hence, it was important to check NF-
B
activation levels not only by VV-mediated expression of PKR but also
upon infection with VV alone. To this end, nuclear extracts from HeLa
cells infected with VV or VV PKR and collected at different times
postinfection were subjected to gel shift assay by using an NF-
B
probe (Fig. 4A). Nuclei from
mock-infected HeLa cells contain a detectable basal activity (lane 1),
and after infection with VV this activity slightly diminishes (lanes 2, 4, 6, and 8). However, after PKR expression NF-
B binding activity
was first detectable at 9 hpi (data not shown) and progressively
increased with time (lanes 5, 7, and 9). Hence, PKR expression from a
VV vector was able to induce a strong NF-
B binding activity. As a
further approach we decided to check whether PKR expressed from VV was
able to induce transactivation of NF-
B-driven reporter vectors. To
do this, we infected HeLa cells with VV PKR or control VV and
transfected them after viral adsorption with either of two different
reporter plasmids, 3enh-
B-ConA-luc (3) (Fig. 4B) or
LTR-luciferase (2) (Fig. 4C). With these assays we were able
to detect an upregulation of levels upon expression of PKR at 18 hpi of
6.84-fold relative to unstimulated HeLa cells with the LTR-luciferase
reporter (Fig. 4C, column 4). Most significantly, by using the highly
NF-
B-inducible 3enh-
B-ConA-luc reporter, luciferase activity in
VV PKR-infected cells (Fig. 4B, column 4) was more than 45-fold higher
than in mock-infected HeLa cells and more than 12-fold higher with
respect to VV-infected cells at 18 hpi. In conclusion, VV-mediated PKR expression significantly induced NF-
B activity. As NF-
B has been
reported to inhibit or promote apoptosis depending on the triggering
stimulus (1, 7, 21, 26, 37, 39, 60, 62), it was important to
evaluate the interaction of PKR-induced NF-
B activity and apoptosis.


View larger version (89K):
[in this window]
[in a new window]
|
FIG. 4.
PKR expression from a VV vector induces NF- B binding
and transactivation. (A) Time course of NF- B binding induced by PKR.
HeLa cells were infected with 8 PFU of wild-type VV (lanes V) per cell
or 4 PFU of VV PKR plus 4 PFU of VV per cell in the presence of 5 mM
IPTG (lanes P) for the times indicated. As a control, HeLa cells were
mock infected for 20 h. Nuclear extracts were analyzed by gel
shift with a [ -32P]dCTP-labeled double-stranded probe
containing two B consensus sites. For the analysis of PKR-induced
NF- B-dependent transactivation, HeLa cells seeded in 6-well plates
were mock infected or infected with 5 PFU of VV or VV PKR per cell.
After 1 h of viral adsorption, 5 mM IPTG was added, and the cells
were transfected with 2 µg of 3enh-ïB-ConA-luc vector (B) or
LTR-luciferase plasmid (C) per well for an additional 5 h. Cells
were collected at the indicated times postinfection and lysed for the
luciferase determination. Duplicate experiments were performed.
|
|
Inhibition of I
B
degradation with proteasome inhibitors
prevents induction of apoptosis by PKR.
It is known that NF-
B
induction is dependent upon the phosphorylation and subsequent
ubiquitination of I
B
. Ubiquitin-tagged I
B
is degraded by
the proteasome releasing NF-
B for migration to the nucleus. As a
first approach to check the role of NF-
B in PKR-induced apoptosis,
the NF-
B induction pathway was blocked by using the specific
proteasome inhibitors, lactacystin and PSI. Lactacystin binds to
various proteasome subunits (14), and PSI inhibits the
chymotrypsin-like activity of the proteasome (19). Traenckner et al. (58) showed that PSI inhibited NF-
B
induction in HeLa cells.
The viability of BSC-40 cells based upon the MTT assay and cellular
apoptosis based upon the ELISA were not affected by concentrations of
up to 60 µM PSI and 40 µM lactacystin. The specificity of
proteasome inhibitor activity was further evaluated by plaque assays
that showed VV replication was not affected by use of the inhibitors (data not shown).
To evaluate the effect of these proteasome inhibitors on PKR-induced
apoptosis, BSC-40 cells were infected with 6 PFU of VV PKR per cell
and, after 1 h of virus adsorption, cells were treated with
different concentrations of lactacystin or PSI, in the absence or
presence of IPTG. As an additional control, BSC-40 cells were infected
with VT7 and VV RL at 3 PFU/cell each, thus expressing the IFN-induced
enzyme RNase L (16). Previously, RNase L has been shown to
activate apoptosis by an unknown pathway not suspected to involve
NF-
B activation (13, 17, 67). Lactacystin and PSI
decreased PKR-induced apoptosis in a dose-dependent manner (Fig.
5A and B). However, these inhibitors did
not affect apoptosis triggered by overexpression of RNase L. As
determined by Western blots, the protein levels of PKR and RNase L were
not affected by treatment with various doses of either proteasome
inhibitor (Fig. 5C and D). These results support the concept that the
NF-
B pathway is involved in the induction of apoptosis by PKR.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 5.
Lactacystin and PSI treatments prevent apoptosis of VV
PKR-infected cells. (A) BSC-40 cells grown in 12-well plates were
infected at a multiplicity of infection (MOI) of 6 with VV PKR in the
presence of 5 mM IPTG with 3 PFU of VT7 and 3 PFU of VV RL per cell or
6 PFU of VV per cell and treated for 24 h with the indicated
amounts of lactacystin. The cells were harvested at 24 hpi for the
determination of apoptosis as previously described. Results are
presented as the fold induction of apoptosis over that for VV-infected
cells. (B) BSC-40 cells grown in 12-well plates were infected at a
total MOI of 6 with VV PKR in the presence of 5 mM IPTG, with 3 PFU
each of VT7 and VV RNase L per cell or with 6 PFU of VV per cell and
treated for 24 h with the indicated amounts of PSI. The cells were
harvested at 24 hpi for the determination of apoptosis. Results are
presented as the fold induction of apoptosis over that for VV-infected
cells. Extracts of the lactacystin treatment (C) and PSI treatment (D)
experiments were separated by SDS-PAGE, transferred to nitrocellulose
membrane, and immunoblotted with antibodies against RNase L and PKR.
All of the ELISA experiments are represented as mean values of
triplicate experiments.
|
|
Coexpression of PKR with a nonphosphorylatable form of I
B
inhibits the induction of apoptosis by PKR.
To evaluate the
interaction of the NF-
B pathway in PKR-induced apoptosis, a
repressor mutant form of I
B
was coexpressed with PKR. The
nonphosphorylatable form of I
B
acts as a nondegradable mutant to
repress NF-
B activation in the cytoplasm in response to different
stimulating signals (36, 60).
Figure 6A shows the construction of the
VV insertional vector for expression of the mutant I
B
. VV
I
B
M expresses, in an IPTG-dependent way, an I
B
SV5-tagged
protein with serines 32 and 36 substituted by alanines (VV I
B
M).
Figure 6B shows an immunoblot analysis with a monoclonal antibody
against the SV5 epitope (45) fused to the I
B
M protein
in its C terminus (47). Clearly, the I
B
protein was
detectable at 6 hpi after IPTG addition. The leakiness of the E. coli operator-repressor pPR35 system observed at 24 hpi has been
noted previously (34).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 6.
VV I B M expresses in an IPTG-dependent way a
tagged mutant form of I B . (A) Map of the pPR35 derived pI B
M (S32, 36A). The plasmid contains an IPTG-inducible copy of I B M
(S32, 36A) fused to the SV5 tag in its C terminus under the regulation
of a hybrid promoter consisting of the VV p4b promoter fused to two
lacI operator (op) units. The plasmid also contains the
lacI repressor gene under the control of the VV p7.5
promoter and was used to obtain recombinant VV by homologous
recombination in TK 143B cells. (B) Western blot time
course analysis of IPTG-dependent expression of I B M by VV
I B M. BSC-40 cells were infected at an MOI of 4 with the virus
and treated with or without 1.5 mM IPTG; they were then scraped and
collected at the indicated times postinfection. Extracts were lysed,
and equal amounts of protein as determined by BCA were analyzed by
SDS-PAGE in conjunction with Western blotting with anti-SV5 monoclonal
antibody.
|
|
Coexpression of PKR and the nonphosphorylatable form of I
B
(I
B
M) significantly blocked PKR-mediated apoptosis (Fig.
7A, compare columns 1 and 3). Similar
results were obtained with different ratios of virus multiplicities
(compare columns 1 and 3 with columns 6 and 7). The apoptosis triggered
by PKR was also blocked by the coexpression of PKR with the African
swine fever virus Bcl-2 homologue (columns 2 and 8) and by the human
Bcl-2 protein (column 5), thus confirming previous results (11,
35). The levels of expression of PKR and I
B
in the
coinfected cultures are shown in the Western blot of Fig. 7B.
Similarly, we were able to detect a decrease in PKR-induced apoptosis
with the expression of I
B
M in other cell lines (Fig. 7C, D, and
E), suggesting that the inhibition of apoptosis induced by I
B
M
expression was not a particular characteristic of BSC-40 cells.



View larger version (52K):
[in this window]
[in a new window]
|
FIG. 7.
Coinfection of VV PKR with VV I B M inhibits
PKR-induced apoptosis. (A) BSC-40 cells grown in 12-well plates were
infected at an MOI of 10 with the viruses indicated in the presence of
5 mM IPTG and harvested at 24 hpi to determine the absorbance at 405 nm. The mean values of triplicate experiments with standard deviations
are given. Columns: 1, 5 PFU of VV PKR and 5 PFU of VV per cell; 2, 5 PFU of VV PKR and 5 PFU of VV aBcl-2 per cell; 3, 5 PFU of VV PKR and 5 PFU of VV I B M per cell; 4, 5 PFU of VV and 5 PFU of VV I B
M per cell; 5, 3 PFU of VV PKR and 7 PFU of hBcl2 per dell; 6, 3 PFU of
VV PKR and 7 PFU of VV I B M per cell; 7, 3 PFU of VV PKR and 7 PFU of VV per cell; 8, 3 PFU of VV PKR and 7 PFU of VV aBcl-2 per cell.
(B) Immunoblot analysis of PKR and I B M expression with the
anti-SV5 tag antibody in the same extracts used to measure apoptosis.
HeLa cells (C), PKR0/0 (D), or PKR+/+ (E) cells
grown in 12-well plates were infected at an MOI of 10 with the viruses
indicated in the presence of 5 mM IPTG and harvested at 24 hpi for the
determination of apoptosis by using the cell death detection ELISA.
Columns: 1, 3 PFU of VV PKR and 7 PFU of VV per cell; 2, 3 PFU of VV
PKR and 7 PFU of VV I B M per cell; 3, 3 PFU of VV PKR and 7 PFU
of VV I B S per cell; 4, 10 PFU of VV per cell. Triplicate
experiments were performed.
|
|
The role of I
B
in preventing the PKR effect on apoptosis was
further evaluated by coexpressing the wild-type I
B
(VV I
B
Wt). Lin et al. (36) demonstrated that overexpression of
wild-type I
B
leads to partial inhibition of NF-
B activity in
alphavirus-infected cells (36). To determine whether
wild-type I
B
inhibits apoptosis in our VV model, BSC-40 cells
were infected with different combinations of virus multiplicities, and
apoptosis was measured at 24 hpi. The inhibition of PKR-induced
apoptosis by coexpression of I
B
Wt was similar to treatments
where PKR was coexpressed with I
B
M (Fig.
8A, compare columns 1 to 4 with columns 5 to 7). Since we have shown that the mechanism involving PKR activation
of NF-
B involves phosphorylation of I
B
on serine 32, the most
probable explanation for the similar behavior of wild-type and mutant
I
B
forms in preventing PKR-induced apoptosis is the high
expression levels of both proteins achieved with our system. The
differences observed in the levels of I
B
when PKR was coexpressed
(Fig. 8B, compare lanes 3 and 4 or lanes 6 and 7) are probably due to the translational abrogation induced by PKR. However, under those conditions there is enough I
B
protein synthesized to reverse the
PKR-mediated effect on apoptosis. These results further confirm that
NF-
B has a direct role in mediating PKR-induced apoptosis.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 8.
Coexpression of increasing amounts of I B Wt or M
equally inhibit induction of apoptosis triggered by PKR. (A) BSC-40
cells grown in 12-well plates were infected at an MOI of 6 with the
viruses indicated in the presence of 5 mM IPTG and harvested at 24 hpi
for the determination of the absorbance at 405 nm. Mean values of
triplicate experiments with standard deviations are given. Columns: 1, 2 PFU of VV PKR and 4 PFU of VV per cell; 2, 2 PFU of VV PKR, 2 PFU of
VV I B M, and 2 PFU of VV per cell; 3, 2 PFU of VV PKR and 4 PFU
of VV I B M per cell; 4, 4 PFU of VV I B M and 2 PFU of VV
per cell; 5, 2 PFU of VV PKR, 2 PFU of VV I B Wt, and 2 PFU of VV
per cell; 6, 2 PFU of VV PKR and 4 PFU of VV I B Wt per cell; 7, 4 PFU of VV I B Wt and 2 PFU of VV per cell. (B) Immunoblot analysis
of PKR and I B M and Wt expression with the anti-SV5 tag antibody
from the same extracts used to measure apoptosis.
|
|
Inhibition of PKR-induced apoptosis by a nonphosphorylatable
I
B
mutant does not prevent translational abrogation and
correlates with the absence of NF-
B binding activity.
Gel shift
assays were also performed to evaluate the effect of PSI and I
B
proteins directly on NF-
B binding activity. As shown in Fig.
9A, not only the expression of I
B
M
or Wt (lanes 5 and 6) proteins but also the treatment with different
doses of PSI (lanes 3 and 4) significantly blocked the NF-
B binding activity induced by the expression of PKR. It is important to note that
the coexpression of PKR with eIF-2
NP produced no effect on
PKR-induced NF-
B binding activity (data not shown). Additionally, prevention of PKR-induced apoptosis by expression of the I
B
M
protein should be a specific event but a trouble intrinsic to the use
of nonphosphorylated substrates could be the nonspecific inhibition of
the target enzyme by the substrate analogue. Thus, we tested whether
I
B
M had any effect on the PKR-induced translational block. We
used the luciferase reporter gene to measure levels of protein
synthesis. A similar level of translational inhibition was found in
cells expressing PKR, coexpressing PKR and I
B
M (Fig. 9B, columns
1 and 3), or coexpressing PKR and the ASFV analogue of Bcl-2 (Fig. 9B,
column 2). Hence, the effects on apoptosis induction (Fig. 9C) by
I
B
M expression are not associated with any effect on
translation. Quantitation of protein synthesis levels by using
[35S]Met-Cys pulse-labeled cells similarly showed that
translation was not affected by I
B
M expression (Fig. 9D)
and demonstrates the functional independence of the PKR-eIF-2
and
PKR-I
B
pathways.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 9.
Coexpression of I B M with PKR inhibits NF- B
activity without affecting translational abrogation. (A) HeLa cells
grown in 100-mm-diameter plates were mock infected or infected with the
viruses indicated in the presence of 5 mM IPTG. When noted, 20 or 60 µM PSI was added to cells after 1 h of viral adsorption. Cells
were collected at 20 hpi, and nuclear extracts were prepared and
analyzed by gel shift assay as described above. Lanes: 1, 8 PFU of VV
per cell; 2 to 4, 4 PFU of VV and 4 PFU of VV PKR per cell in the
absence of PSI (lane 2) or with 20 or 60 µM (lanes 3 and 4, respectively); 5, 4 PFU of VV PKR and 4 PFU of VV I B M per cell;
6, 4 PFU of VV PKR and 4 PFU of VV I B WT per cell; 7, mock
infected. (B) BSC-40 cells grown in 12-well plates were infected at an
MOI of 6 with the viruses indicated in the presence of 5 mM IPTG,
transfected 1 h later with 0.5 µg of pPR15, and harvested at 24 hpi; half of the samples were lysed in buffer for luciferase
determination as described in Materials and Methods. Mean values of
relative luciferase units (n = 3) measured in equal
extracts, along with the standard deviations, are given. Columns: 1, 2 PFU of VV PKR and 4 PFU of VV per cell; 2, 2 PFU of VV PKR and 4 PFU of
VV aBcl-2 per cell; 3, 2 PFU of VV PKR and 4 PFU of VV I B M per
cell; 4, 4 PFU of VV I B M and 2 PFU of VV per cell. (C) The other
half of the samples were processed according to the manufacturer's
instructions, and the absorbance at 405 nm was determined as a measure
of apoptosis. Mean values of triplicate experiments with standard
deviations are given. (D) BSC-40 cells were infected with the indicated
viruses at the indicated concentrations, and the
[35S]Met-Cys incorporation during a 1-h pulse was
measured beginning at 12 hpi as described in Materials and Methods.
Specific activities (in counts per minute per microgram of protein) are
represented as the mean value from two experiments, along with the
standard deviation.
|
|
 |
DISCUSSION |
Although previous studies by us and others have demonstrated that
activation of PKR leads to induction of apoptosis (15, 33),
the molecular mechanism by which PKR activates the apoptotic pathway
remains to be defined. Since eIF-2
and I
B
have been proposed
as downstream mediators of PKR effects (29, 48), it is
important to establish the contribution of both pathways, if any, in
the process of apoptosis. Additionally, in view of the biological
importance of PKR as a controlling factor of viral infections (27,
49), it is of interest to know the contribution of both
substrates to apoptosis induced by PKR within the context of virus
infection. Hence, in this investigation we describe a virus-cell system
in which activation of eIF-2
-dependent or NF-
B-dependent pathways
by PKR can be selectively blocked. Our model system is ideally suited
for the sensitive dissection of PKR-mediated effects in vivo. Although
the coexpression of PKR and its substrates is within the context of VV
infection in a background of normal cell constituents, the regulated
expression allows a direct interaction without regard to temporal or
localization issues that may complicate assays in other in vivo model
systems. It should be pointed out that conclusions obtained to date
with this system have been validated by different approaches, such as
the use of cells derived from PKR and RNase L knockout mice (15,
67), or with different expression systems (13, 51).
The overriding issue of this study was to evaluate the contribution of
the phosphorylation of eIF-2
and the activation of NF-
B to PKR
induced apoptosis. Coexpressing a dominant negative mutant form of
eIF-2
with PKR caused a significant reversion of the translational
block conditioned by eIF-2
phosphorylation concomitantly with
inhibiting the induction of apoptosis. These results are in agreement
with previous transient-expression studies (51) and suggest
that translational control is important in the induction of apoptosis
by PKR. The finding that the NF-
B pathway is involved in the
transcription of death genes (31, 57, 65, 66) and that PKR
has a regulatory impact on that pathway (29, 30) also
suggest a link of PKR-induced NF-
B activation and apoptosis.
The use of two different proteasome inhibitors that block NF-
B
activation and also inhibit apoptosis induced by PKR in our system
supports an interaction between this transcription factor and
PKR-induced apoptosis. Although several parameters were unaffected in
our virus-cell system after treatment with both drugs and, additionally, the use of other IFN-induced apoptosis-triggering enzymes, such as RNase L, served as a control, the cellular functions other than NF-
B activity (58) could be altered by
inhibiting the proteasome (14). However, these data provided
a basis for further studies to elucidate the role of NF-
B on
PKR-induced apoptosis. The key step in the activation of
NF-
B-dependent transcription is the inducible degradation of the
NF-
B inhibitor I
B
, which in turn makes possible NF-
B
migration to the nucleus. I
B
phosphorylation of serines 32 and 36 is the signal that induces the degradation of this inhibitor
(47). Thus, a mutant form which cannot be phosphorylated on
these residues acts as a repressor (60, 62, 63). In
addition, we have shown that the role of PKR in the activation of
NF-
B involves I
B
phosphorylation on serine 32, one of the two
residues responsible for phosphorylation-mediated NF-
B activation.
The expression of nonphosphorylatable forms of I
B
has been widely
used to inhibit NF-
B activation in other systems (36,
60). In our system, we observed a significant decrease in
apoptosis induction when the I
B
mutant was coexpressed with PKR.
In addition, the expression of not only a nonphosphorylatable mutant
form of I
B
but also of wild-type I
B
abrogated PKR-induced apoptosis. Lin et al. (36) expressed I
B
Wt while
checking the effect of I
B
on alphavirus-induced apoptosis and
observed an inhibitory effect on NF-
B activity. The high levels of
expression of the I
B
Wt protein likely explains its inhibitory
effect on PKR-induced cell death. However, we cannot exclude some
peculiarity occurring in the PKR-mediated mechanism of NF-
B
activation that could account for this result. The specificity of the
effects caused by expression of I
B
proteins was confirmed by
checking the translational state of the cells. Luciferase reporter
assays and metabolic labeling studies showed that in cells coexpressing PKR and I
B
M, despite observing a rescue of apoptosis induction that was correlated with the absence of NF-
B binding activity, translation was significantly inhibited. This is the first evidence of
a transcriptional pathway and not only a translational block in the
commitment of apoptosis by PKR.
The identities of putative NF-
B genes that are upregulated and
induce cell death upon PKR expression are not known. Transcription of
several death-inducing genes is regulated by NF-
B. One of these
genes is the FasL gene, which has consensus
B-binding sites in its
promoter (55). Its NF-
B-dependent upregulation has been described as the mechanism of apoptosis induced by DNA-damaging agents
in T lymphocytes (26). Alternatively, Fas mRNA levels also
increase upon influenza virus infection, with the possible involvement
of PKR (56). Upregulation of Fas mRNA levels in PKR+/+ but not in PKR0/0 mouse embryo
fibroblasts after treatment with different apoptotic stimuli has also
been observed (15). Although analysis of the human Fas
promoter region (8) reveals the existence of two putative
NF-
B consensus sequences, NF-IL6 has been proposed as the
transcription factor mediating Fas induction in the influenza virus
infection model (61). In the PKR-inducible VV system
described here, we found that basal transcription of FasL mRNA was not
increased upon PKR expression. However, we observed that Fas mRNA
levels are upregulated after PKR activation at 6 hpi (unpublished
observations). A more detailed analysis of mRNA levels upon PKR
expression must be completed. Other candidate mRNAs that are
NF-
B-induced death genes that have been previously characterized
include several transcription factors, such as IRF-1 (30,
57) c-Myc (31), and p53 (65, 66), and
caspases, such as caspase-1 (12).
Using different approaches, we have shown the involvement of NF-
B
and eIF-2
in cell death induced upon PKR expression. However, a
global explanation of the role of both PKR substrates in apoptosis is
needed. One possible explanation is a different timing of events triggered by PKR phosphorylation of I
B
and eIF-2
. Hence, the amount of I
B
phosphorylated required for the activation of
NF-
B-dependent transcription is surpassed sooner than the threshold
of phosphorylated eIF-2
to a degree sufficient to lead to protein
synthesis inhibition. Thus, a window of time exists for the translation
of death genes. It is proposed that the inhibition of apoptosis in
cells coexpressing PKR and the S51A mutant of eIF-2
is due to the
translation at later times of selected mRNAs, such as inhibitors of
death gene products, as observed with the antiapoptotic mechanism
triggered by other signals of apoptosis such as TNF-
(63). Thus, the inhibition of protein synthesis mediated by
eIF-2
phosphorylation is required for cell commitment to apoptosis.
This could be interpreted as a security mechanism of the cell that
regulates entry into the cell death program depending on the dsRNA
levels (probably as a sensor of the status of viral infection). An
alternative explanation for the observed results is that PKR acts as a
selective translation inhibitor. Hence, it is possible that a certain
class of mRNAs with several AUGs upstream of the initiation codon could be translated despite high levels of eIF-2
phosphorylation, as has
been observed with GCN4 mRNA in yeast cells upon GCN2 activation (23). This could account for the inhibition of apoptosis
both when NF-
B activation is blocked and when eIF-2
NP is
expressed. Additionally, this hypothesis also explains the fact that
the only expression of an S51D eIF-2
mutant that mimics the
phosphorylated eIF-2
induced apoptosis in 3T3 cells (51).
A recent report (51) has demonstrated that 3T3 cells
expressing a noncatalytic K296P mutant of the PKR are resistant to apoptosis upon serum starvation, whereas control cells are not. In
addition, Grimm et al. (21) found that apoptosis induced by
serum starvation in human embryonic kidney (HEK) 293 cells was
dependent on NF-
B activity. Our work provides a clue to linking these two independent observations and suggests a role for NF-
B activity induced by PKR as a signal mediating apoptosis induction in
serum-deprived cells. Blocking PKR action and inhibition of apoptosis
are two common strategies used by different viruses to circumvent the
clearance of cells (27, 40, 49, 59). Given the fact that
apoptosis induced by such viruses as dengue virus (38) or
alphavirus (37) is dependent on NF-
B activation, it is
conceivable that PKR may have a key role in the induction of cell death
upon infection by certain viruses. Hence, PKR would have a dual role in
viral clearance, acting not only by inhibiting virus replication at the
translational level but also by inducing apoptosis and thus preventing
the production and spread of nascent viral particles that would escape
immune surveillance.
In conclusion, the results presented here provide the first evidence
for a PKR-NF-
B interaction mediating the apoptosis pathway induced
by PKR. Moreover, our findings define the role of eIF-2
in apoptosis
in the course of a virus infection.
 |
ACKNOWLEDGMENTS |
We thank R. E. Randall (University of Glasgow, Glasgow,
Scotland) for the SV5 monoclonal antibody (from the NIBSC-MRC AIDS Reagent Project), J. Hershey (University of California) for the eIF-2
plasmid, M. J. Clemens (St. George's Hospital, London, United Kingdom) and César de Haro (CBMSO) for the eIF-2
monoclonal antibody, and Fernando Arenzana (Institut Pasteur, Paris,
France) for providing the NF-
B reporter plasmids. We also thank C. Weissman (University of Zurich, Zurich, Switzerland) for the generous
gift of the 3T3-like PKR0/0 and PKR+/+ cells.
We especially thank Juan Pablo Albar from the Department of Immunology
and Oncology, Centro Nacional de Biotecnologia, for the production of
the PKR synthetic peptide. We thank Manuel Collado, Carmen Rivas, Don
Roth, and Isabel Vázquez for their critical reading of the
manuscript and helpful suggestions and Victoria Jiménez and Laura
Giménez for expert technical assistance.
This investigation was supported by grants SAF 95 0022 and PM98-0112
from the Comision Interministerial de Ciencia y Tecnologia of Spain (to
M.E.) and grants from Fundación Caja de Madrid and Ministerio de
Educación y Ciencia MEC (SAF 96/186) (to J.A.). J.G. was the
recipient of an FPI fellowship from the Spanish MEC.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Centro Nacional
de Biotecnología, CSIC, Campus Universidad Autónoma,
28049 Madrid, Spain. Phone: 34-91-585-4503. Fax: 34-91-585-4506. E-mail: mesteban{at}cnb.uam.es.
 |
REFERENCES |
| 1.
|
Abbaddie, C. N.,
F. Kabrun,
F. Bouali,
B. Vandenbunder, and P. Enrietto.
1993.
High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro.
Cell
75:899-912[Medline].
|
| 2.
|
Alcamí, J.,
T. Lain de Lera,
L. Folgueira,
M. A. Pedraza,
J. M. Jacqué,
F. Bachelerie,
A. R. Noriega,
R. T. Hay,
D. Harrich,
R. B. Gaynor,
J. L. Virelizier, and F. Arenzana-Seisdedos.
1995.
Absolute dependence on B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes.
EMBO J.
14:1552-1560[Medline].
|
| 3.
|
Arenzana-Seisdedos, F.,
B. Fernandez,
J. Dominguez,
M. Jaqué,
D. Thompson,
M. T. Díaz-Meco,
J. Moscat, and J. L. Virelizier.
1993.
Phosphatidylcholine hydrolysis activates NF- B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes.
J. Virol.
67:6596-6604[Abstract/Free Full Text].
|
| 4.
|
Arenzana-Seisdedos, F.,
J. Thompson,
M. S. Rodriguez,
F. Bachelerie,
D. Thomas, and R. T. Hay.
1995.
Inducible nuclear expression of newly synthesized I B negatively regulates DNA-binding and transcriptional activities of NF- B.
Mol. Cell. Biol.
15:2689-2696[Abstract].
|
| 5.
|
Baeuerle, P. A., and T. Henkel.
1994.
Function and activation of NF- B in the immune system.
Annu. Rev. Immunol.
12:141-179[Medline].
|
| 6.
|
Baldwin, A. S., Jr.
1996.
The NF- B and I B proteins: new discoveries and insights.
Annu. Rev. Immunol.
14:649-681[Medline].
|
| 7.
|
Beg, A., and D. Baltimore.
1996.
An essential role for NF- B in preventing TNF- -induced cell death.
Science
274:782-784[Abstract/Free Full Text].
|
| 8.
|
Behrmann, I.,
H. Walczac, and P. H. Krammer.
1994.
Structure of the human APO-1 gene.
Eur. J. Immunol.
24:3057-3062[Medline].
|
| 9.
|
Belich, M. P.,
A. Salmeron,
L. H. Johnston, and S. C. Ley.
1999.
TPL-2 kinase regulates the proteolysis of the NF- B-inhibitory protein NF- B1 p105.
Nature
397:363-368[Medline].
|
| 10.
|
Braiser, A. R.,
J. E. Tate, and J. F. Habener.
1989.
Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines.
BioTechniques
7:1116-1122[Medline].
|
|